Previous Conferences - 1998 - National Report Card on STDS
CDC Issues National Report Card on STDs - Media Release
- Gonorrhea and Syphilis Down, but Not Beaten
- Chlamydia Continues to Spread Widely
Syphilis and gonorrhea have reached all-time lows in the U.S. overall, but a number of cities in the South and Northeast continue to battle high rates of both diseases, according to new data released today by the Centers for Disease Control and Prevention (CDC).
Fifteen cities share the grim distinction of leading the nation in reported rates of both STDs. The cities that made the list for highest rates of both gonorrhea and syphilis in 1997 are (in alphabetical order) Atlanta, Baltimore, Birmingham, Chicago, Detroit, Memphis, Milwaukee, Nashville, Newark, New Orleans, Norfolk, Oklahoma City, Richmond, St. Louis, and Washington, D.C.
CDC issued the "report card" on STD prevention at the 1998 National STD Prevention Conference which opened today in Dallas, Texas. CDC updated leading experts from across the nation on the status of the STD epidemic in the U.S., as the group came together to design new strategies for combating STDs in the 21st century.
According to CDC, the new data help identify areas where increased attention must be focused in the next era of STD prevention.
"For far too long, our nation has accepted the consequences of STDs as an unavoidable reality," stressed Helene Gayle, M.D., M.P.H., Director of CDC's National Center for HIV, STD, and TB Prevention (NCHSTP). "Fortunately, for the health of women and children, things are beginning to change. But we must gain momentum if we are serious about further reducing the still staggering toll."
According to Gayle, while gonorrhea and syphilis, the STDs we have been battling the longest, are now primarily isolated geographically, other diseases such as chlamydia, herpes, and human papillomavirus (HPV) remain extremely widespread.
The latest estimates indicate that 15 million Americans become newly infected with an STD each year, yet they remain one of the most under recognized health threats.
In one of his first national appearances as CDC Director, Jeffrey Koplan, M.D., M.P.H., will announce that a key priority of his agency will be to improve national STD prevention and treatment efforts overall and, specifically, to eliminate syphilis in the U.S. According to Koplan, syphilis is now confined to only 1% of U.S. counties and has never been more vulnerable to elimination.
"At no time in history have the prospects for eliminating syphilis been better," stressed Koplan. "We have the rare opportunity to add syphilis next to malaria and cholera on the short list of diseases we have beaten in the United States. But if we don't take the opportunity now, we will lose our chance."
Koplan's full statement on a national response to the hidden epidemics of STDs and syphilis elimination will be released on Wednesday, December 9, 1998.
Syphilis elimination efforts are critical to improving infant health, slowing the spread of HIV infection, and to reducing racial disparities in health. Untreated syphilis during pregnancy results in infant death in up to 40% of cases, and over 65% of cases of congenital syphilis are among African Americans. Moreover, syphilis is believed to be accelerating the spread of the HIV epidemic, particularly in communities of color. Given the disproportionate toll of the disease among African Americans, syphilis and its preventable consequences constitute one of the most glaring racial gaps in health status in the United States. "CDC is committed to eliminating this gap," added Koplan.
In her opening remarks to the conference, Judith Wasserheit, M.D., M.P.H., Director of NCHSTP's Division of STD Prevention, identified expanded detection and treatment of chlamydia as another urgent priority for national STD prevention efforts.
CDC receives more reports of chlamydia each year than any other infectious disease. While the disease can be easily treated and cured if detected early, it often has no symptoms and goes undiagnosed. Untreated, chlamydia can lead to severe health consequences for women, including infertility and potentially fatal tubal pregnancies.
According to CDC, the toll of chlamydia can be reduced with existing knowledge, technology, and treatments.
"The good news is we have the power to make a tremendous difference in STD prevention and treatment," stressed Wasserheit. "With many diseases today, we are still searching frantically for the solutions. With STDs, we need only to make better use of the sustained solutions we already have."
Wasserheit released new figures on chlamydia for the nation, which demonstrate a significant reduction in the percentage of young women with chlamydia in areas with widespread screening and treatment programs. She stressed the importance of expanding these efforts throughout the United States. While the programs can make a dramatic difference in preserving women's reproductive health, they currently reach only 50% of women at risk in 20 states, and less than 15% in 30 states.
The latest data from screening in family planning clinics nationwide demonstrate a 67% reduction in the proportion of women ages 15-24, infected with chlamydia in the Northwest (Washington, Oregon, Idaho, and Alaska) since they initiated large scale screening efforts in 1988. Similar declining trends are now beginning in other regions which have recently initiated screening and treatment programs -- with the largest burden of disease remaining in the South.
The ten states with the most severe level of chlamydia among young women ages 15-24 tested in family planning clinics, include Arkansas (11.2% of young women infected), South Carolina (11.1%), Mississippi (11.0%), North Carolina (10.7%), Alabama (10.6%), Louisiana (10.2%), Texas (8.2%), Georgia (7.6%), Illinois (7.4%), and Florida (7.2%).
Improved treatment of STDs is vital, not only to reduce the severe reproductive consequences of these diseases, but also to stem the sexual spread of HIV infection. Because infection with these STDs greatly increases a person's risk of both acquiring and spreading HIV infection, improved STD treatment is critical to slowing the HIV epidemic.
"It is unconscionable that diseases that can be cured with one dose of antibiotics continue to exact such a tremendous toll on the nation," stressed Wasserheit. "We simply must reach people with the prevention, screening, and treatment needed to reduce this toll."